From the CDC
Drugs | Duration | Interval | Minimum-doses |
---|---|---|---|
Isoniazid | 9 months | Daily | 270 |
Twice weekly* | 76 | ||
Isoniazid | 6 months | Daily | 180 |
Twice weekly* | 52 | ||
Isoniazid and Rifapentine | 3 months | Once weekly* | 12 |
Rifampin | 4 months | Daily | 120 |
*Use Directly Observed Therapy (DOT)
From AAFP (2014)
Drug | Duration | Dosing | Minimum number of doses | Maximal oral dose | ||
---|---|---|---|---|---|---|
Adults | Children | |||||
Isoniazid |
Nine months |
Daily† |
270 |
5 mg per kg (300 mg) |
10 to 20 mg per kg (300 mg) |
|
Twice weekly‡ |
76 |
15 mg per kg (900 mg) |
20 to 40 mg per kg (900 mg) |
|||
Isoniazid |
Six months |
Daily |
180 |
5 mg per kg (300 mg) |
10 to 20 mg per kg (300 mg) |
|
Twice weekly‡ |
52 |
15 mg per kg (900 mg) |
20 to 40 mg per kg (900 mg) |
|||
Isoniazid plus rifapentine (Priftin)§ |
Three months |
Weekly‡ |
12 |
Isoniazid: 15 mg per kg (900 mg) |
||
Rifapentine:
|
||||||
Rifampin |
Four months |
Daily |
120 |
10 mg per kg (600 mg) |
10 to 20 mg per kg (600 mg) |
*—Including screening test window prophylaxis.
†—Preferred regimen for children two to 11 years of age.
‡—Dosing should be directly observed.
§—The 12-dose regimen does not replace other guidelines, and is not recommended for children younger than two years, pregnant women, women who may become pregnant during treatment, patients with human immunodeficiency virus (HIV) infection who are receiving antiretroviral treatment, or patients who have latent tuberculosis infection with presumed isoniazid or rifampin resistance. It is approved for use in HIV-positive patients who are not receiving antiretroviral therapy.
References
https://www.cdc.gov/tb/publications/factsheets/treatment/ltbitreatmentoptions.htm
Am Fam Physician. 2014 Jun 1;89(11):889-896. http://www.aafp.org/afp/2014/0601/p889.html